kabutan

Sumitomo Pharma Co., Ltd.(4506) Summary

4506
TSE Prime
Sumitomo Pharma Co., Ltd.
1,851.0
JPY
-84.0
(-4.34%)
Apr 28, 3:30 pm JST
11.62
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
1,844.1
Apr 28, 11:48 pm JST
Summary Chart Historical News Financial Result
PER
8.1
PBR
2.87
Yield
ー%
Margin Trading Ratio
4.82
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,900.0 JPY 11.92 USD
Previous Close Apr 27
1,935.0 JPY 12.13 USD
High Apr 28, 9:00 am
1,942.0 JPY 12.18 USD
Low Apr 28, 9:37 am
1,822.0 JPY 11.43 USD
Volume
13,028,100
Trading Value
0.02T JPY 0.15B USD
VWAP
1858.59 JPY 11.67 USD
Minimum Trading Value
185,100 JPY 1,162 USD
Market Cap
0.83T JPY 5.23B USD
Number of Trades
16,562
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
17,870
1-Year High Feb 20, 2026
143,709
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 13,314,000 9,448,400 0.71
Apr 17, 2026 4,057,600 8,845,900 2.18
Apr 10, 2026 1,899,700 9,399,500 4.95
Apr 3, 2026 288,700 9,651,000 33.43
Mar 27, 2026 468,600 9,236,200 19.71
Company Profile
Sumitomo Pharma Co., Ltd. is a mid-sized pharmaceutical company originating from the Sumitomo Chemical group. The company focuses on developing drugs in the areas of psychiatry and neurology, oncology, and regenerative medicine.
Sector
Pharmaceuticals
Sumitomo Pharma's core business is the manufacturing, procurement, and sales of prescription pharmaceuticals, while also dealing with medical devices. The company prioritizes psychiatry, neurology, and oncology as its key therapeutic areas. In Japan, Sumitomo Pharma conducts manufacturing and sales of prescription pharmaceuticals through its subsidiaries. Additionally, through a joint venture with its parent company Sumitomo Chemical, it engages in contract development and manufacturing in the field of regenerative medicine and cell therapy. Sumitomo Pharma is also actively expanding globally, with operations in North America, China, Southeast Asia, and Taiwan. The company has established subsidiaries in various regions to conduct local pharmaceutical manufacturing, sales, and information provision activities.